Phosphagenics, Nippon Zoki Pharmaceuticals Co. Ltd. deal

Following a March 2012 evaluation deal, the companies partnered to develop Phosphagenics' topical TPM/diclofenac

Read the full 145 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE